Showing results (11-20 of 388) with videos related to
Sort By:
Pageof 39
Current Medicinal Chemistry|November 30, 2010
New therapeutic approaches targeted at the late stages of the HIV-1 replication cycleYan Jiang, Xinyong Liu, Erik De ClercqCurrent Medicinal Chemistry|December 18, 2009
Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigmPeng Zhan, Xinyong Liu, Erik De ClercqCurrent Medicinal Chemistry|June 10, 2008
Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivativesPeng Zhan, Xinyong Liu, Erik De ClercqMini Reviews in Medicinal Chemistry|April 10, 2009
Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitorsJiyan Zhang, Xinyong Liu, Erik De ClercqCurrent HIV Research|January 20, 2009
Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transportYuan Cao, Xinyong Liu, Erik De ClercqJournal of Medicinal Chemistry|June 19, 2015
Strategies for the Discovery of Target-Specific or Isoform-Selective ModulatorsPeng Zhan, Yukihiro Itoh, Takayoshi Suzuki, et al.Current Topics in Medicinal Chemistry|August 28, 2014
Medicinal chemistry of small molecule CCR5 antagonists for blocking HIV-1 entry: a review of structural evolutionYe Tian, Dujuan Zhang, Peng Zhan, et al.Expert Opinion on Therapeutic Patents|July 12, 2016
Pyrazolo[1,5-a]pyrimidine-based macrocycles as novel HIV-1 inhibitors: a patent evaluation of WO2015123182Lin Sun, Ping Gao, Peng Zhan, et al.Recent Patents on Anti-Cancer Drug Discovery|November 3, 2016
Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)Peng Zhan, Xueshun Wang, Xinyong Liu, et al.Current Pharmaceutical Design|January 25, 2013
Recent advances of diaryl ether family as HIV-1 non-nucleoside reverse transcriptase inhibitorsXuwang Chen, Shufang Ding, Peng Zhan, et al.Pageof 39